What is bttn?
bttn. operates as a medical supply procurement platform, integrating technology, web-based ordering, and big data insights. The company's core objective is to dismantle exclusive and restrictive contracts, thereby democratizing product access for essential workers. By leveraging its platform, bttn. aims to streamline the procurement process and provide greater transparency and efficiency in the medical supply chain.
How much funding has bttn raised?
bttn has raised a total of $26.5M across 2 funding rounds:
Angel/Seed
$6.5M
Series A
$20M
Angel/Seed (2021): $6.5M with participation from Fuse and Amol Deshpande
Series A (2022): $20M led by Tiger Global Management and Fuse
Key Investors in bttn
Tiger Global Management
Tiger Global Management is an investment firm that deploys capital across both public and private markets, founded in 2001 and headquartered in New York City.
Fuse
Fuse is an entity that has participated in multiple funding rounds for bttn., indicating a sustained interest in the company's growth and market strategy.
Amol Deshpande
Amol Deshpande is an individual investor who provided backing during bttn.'s early Angel/Seed funding stage, signaling early confidence in the company's vision.
What's next for bttn?
With the recent major strategic investment, bttn. is poised for significant expansion and operational enhancement. The company's focus on technology and data-driven insights suggests a strategic push towards further platform development and market penetration. This Series A funding round, following earlier seed capital, indicates a transition towards scaling operations and solidifying its market position as a key player in medical supply procurement. Future initiatives will likely involve expanding its network of suppliers and customers, enhancing its data analytics capabilities, and potentially exploring new service offerings to better serve the healthcare industry.
See full bttn company page
